Effects of Riboflavin in Mitigating Muscle Soreness in Ultra-marathon Athletes
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The aim of this project is to investigate the effects of riboflavin, also known as vitamin
B2, on preventing delayed onset muscle soreness (DOMS) in ultramarathon athletes through a
randomized placebo-controlled study.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio